- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Amicus Therapeutics Inc+ Add to Watchlist
AM6:GR1.311 EUR 0.100 7.09%
As of 02:01:40 ET on 04/16/2014.
Company Profile for Amicus Therapeutics Inc (AM6)
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.
Amicus Therapeutics Inc
Key Executives for Amicus Therapeutics Inc (AM6)
|John F CrowleyChairman/CEO||William D Baird III "Chip"Chief Financial Officer|
|Bradley L CampbellChief Operating Officer||Peter M MacalusoVP/Secretary/Counsel|
|John R KirkVP:Regulatory Affairs||Ken ValenzanoVP:Pharmacology|
|Kenneth W PeistVP:Intellectual Property||Enrique DiloneVP:Technical Operations|
|Sara PellegrinoDirector:Investor Relations||Daphne QuimiController|